Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paul-James Jones is active.

Publication


Featured researches published by Paul-James Jones.


Tetrahedron Letters | 1993

A simple and effective enantiomeric synthesis of a chiral primary amine

Clara K. Miao; Ronald John Sorcek; Paul-James Jones

Abstract Catalytic reduction of chiral 2-(2-pyridyl)-1,3-oxazolidines and 2-pyridyl imines derived from ( R )-phenylglycinol and ( R )-valinol afforded high diasteriomeric selectivity. Upon oxidative cleavage, the S - primary amine with high ee was obtained.


Bioorganic & Medicinal Chemistry Letters | 1993

Preliminary structural analysis of the mutations selected by non-nucleoside inhibitors of HIV-1 reverse transcriptase

Liang Tong; Mario G. Cardozo; Paul-James Jones; Julian Adams

Abstract The crystal structure of HIV reverse transcriptase complexed with nevirapine showed that most of the mutations that confer resistance to non-nucleoside inhibitors of RT are clustered around the nevirapine binding pocket. Establishment of favorable interactions with conserved residues in this pocket is essential for the design of second generation RT inhibitors.


Bioorganic & Medicinal Chemistry | 1994

Herpes simplex virus ribonucleotide reductase subunit association inhibitors: the effect and conformation of β-alkylated aspartic acid derivatives

Neil Moss; Robert Deziel; Jean-Marie Ferland; Sylvie Goulet; Paul-James Jones; Scott F. Leonardo; T. Phil Pitner; Raymond Plante

Incorporating beta-alkylated aspartic acid derivatives into herpes simplex virus ribonucleotide reductase subunit association inhibitors can improve inhibitor potency up to 50 times over the corresponding inhibitors containing an unsubstituted aspartic acid. A combination of NMR studies, conformational analysis, and molecular mechanics calculations suggests that the beta-alkyl group improves inhibitor potency by favoring the bioactive conformation of the critical aspartic acid carboxyl group. Further support for this hypothesis is provided by a potent conformationally restricted aspartic acid derivative in which the carboxyl group is locked in the putative bioactive conformation.


Journal of Organic Chemistry | 2017

Development of a 13C NMR Chemical Shift Prediction Procedure Using B3LYP/cc-pVDZ and Empirically Derived Systematic Error Correction Terms: A Computational Small Molecule Structure Elucidation Method

Dongyue Xin; C. Avery Sader; Om Chaudhary; Paul-James Jones; Klaus Wagner; Christofer S. Tautermann; Zheng Yang; Carl A. Busacca; Reginaldo A. Saraceno; Keith R. Fandrick; Nina C. Gonnella; Keith Horspool; Gordon Hansen; Chris H. Senanayake

An accurate and efficient procedure was developed for performing 13C NMR chemical shift calculations employing density functional theory with the gauge invariant atomic orbitals (DFT-GIAO). Benchmarking analysis was carried out, incorporating several density functionals and basis sets commonly used for prediction of 13C NMR chemical shifts, from which the B3LYP/cc-pVDZ level of theory was found to provide accurate results at low computational cost. Statistical analyses from a large data set of 13C NMR chemical shifts in DMSO are presented with TMS as the calculated reference and with empirical scaling parameters obtained from a linear regression analysis. Systematic errors were observed locally for key functional groups and carbon types, and correction factors were determined. The application of this process and associated correction factors enabled assignment of the correct structures of therapeutically relevant compounds in cases where experimental data yielded inconclusive or ambiguous results. Overall, the use of B3LYP/cc-pVDZ with linear scaling and correction terms affords a powerful and efficient tool for structure elucidation.


Journal of Pharmaceutical Sciences | 2009

Drug–Excipient Complexation in Lipid Based Delivery Systems: An Investigation of the Tipranavir-1,3-Dioctanolyglycerol Complex

Shirlynn Chen; Mayur S. Dudhedia; Zeren Wang; Richard T. Darrington; Toby Tamblyn; John A. Smoliga; Paul-James Jones; Steven L. Krill

This report describes the solubility properties of a poorly soluble drug-excipient complex in a lipid based formulation. Tipranavir (TPV) was used as the model drug and 1,3-dioctanoylglycerol (DOG) as the excipient. The TPV-DOG complex was prepared by dissolving TPV and DOG in ethanol at 60 degrees C followed by evaporation of ethanol. The formation of the complex with a 4:1 TPV-to-DOG molar ratio was confirmed by XRPD, DSC, and NMR. At 25 degrees C, total solubility of TPV decreased with increasing DOG concentration. The solubility properties of the TPV-DOG complex can be described by two simultaneous equilibria: a liquid-solid phase equilibrium of the complex and a species equilibrium among the various species in the liquid phase. A model equation was derived accordingly with two parameters, the intrinsic solubility of the complex (S(o)), and the solution complex constant (K(41)). The model was in good agreement with experimental results. The values of S(o) and K(41) are 0.0186 +/- 0.0025 (M) and 21.97 +/- 7.19 (1/M(4)), respectively. The equation can successfully predict the concentrations of total and free TPV as a function of DOG in the formulation. The approach developed provides a useful tool for rationale selection of excipients and their levels to avoid drug precipitation in lipid based formulations.


Journal of Organic Chemistry | 2018

DiCE: Diastereomeric in Silico Chiral Elucidation, Expanded DP4 Probability Theory Method for Diastereomer and Structural Assignment

Dongyue Xin; Paul-James Jones; Nina C. Gonnella

NMR chemical shift prediction at the B3LYP/cc-pVDZ level of theory was used to develop a highly accurate probability theory algorithm for the determination of the stereochemistry of diastereomers as well as the regiochemistry. DFT-GIAO calculations were performed for each conformer using geometry optimization and a CPCM solvent model. Boltzmann averaged shielding constants were converted to chemical shifts for 1H and 13C, using the generalized linear scaling terms determined in four different solvents for 1H and 13C and extended to 15N in DMSO. The probability theory algorithm, D iCE, was based on the DP4 method and developed for 1H, 13C, and 15N NMR using individual and combined probability data. The chemical shift calculation errors were fitted to a Students t-distribution for 1H and 13C and a normal distribution for 15N. The application yielded a high accuracy for structural assignment with a low computational cost.


Journal of Pharmaceutical Sciences | 2016

Structure Elucidation of Poly-Faldaprevir: Polymer Backbone Solved Using Solid-State and Solution Nuclear Magnetic Resonance Spectroscopy

Nina C. Gonnella; Carl A. Busacca; Li Zhang; Anjan Saha; Jiang-Ping Wu; Guisheng Li; Mark S. Davis; Thomas Offerdahl; Paul-James Jones; Lars Herfurth; Tim Reddig; Klaus Wagner; Michael Niemann; Ulrike Werthmann; Julia Grupe; Helmut Roos; Gaby Reckzügel; Andreas Ding

A large-scale synthesis of the hepatitis C virus drug Faldaprevir revealed precipitation of an unknown insoluble solid from methanol solutions of the drug substance. The unknown impurity was determined to be a polymer of Faldaprevir based on analytical methods that included size exclusion chromatography in combination with electrospray ionization mass spectrometry, solution nuclear magnetic resonance (NMR), matrix-assisted laser desorption ionization-time of flight, ultracentrifugation, elemental analysis, and sodium quantitation by atom absorption spectroscopy. Structure elucidation of the polymeric backbone was achieved using solid-state NMR cross-polarization/magic angle spinning (CP/MAS), cross polarization-polarization inversion, and heteronuclear correlation (HETCOR) experiments. The polymerization was found to occur at the vinyl cyclopropane via a likely free radical initiation mechanism. Full proton and carbon chemical shift assignments of the polymer were obtained using solution NMR spectroscopy. The polymer structure was corroborated with chemical synthesis of the polymer and solution NMR analysis.


Journal of Pharmaceutical and Biomedical Analysis | 2012

Probing the cation binding modes of macrocyclic HCV protease inhibitor BILN 2061 by multinuclear NMR.

Carl A. Busacca; Paul-James Jones; Scot Campbell; Anjan Saha; Nina C. Gonnella; Chris H. Senanayake

The ability of the macrocyclic HCV protease inhibitor BILN 2061 to bind different classes of cations has been studied by (15)N, (13)C, and (1)H NMR. (15)N NMR experiments were performed at natural abundance or with isotopically labeled materials. Three classes of cations: alkali metals, alkaline earth metals, and transition metals, were examined, using two members of each class. The behavior of each cation class was found to be different, and provided insight into how metal ions interact with the molecular scaffold. These specific interactions were uncovered by examining coordination shifts, NOE correlations, and line broadening across all three nuclei.


Journal of Organic Chemistry | 2004

Electronic Control of Chiral Quaternary Center Creation in the Intramolecular Asymmetric Heck Reaction

Carl A. Busacca; Danja Grossbach; Scot Campbell; Yong Dong; Magnus Eriksson; Robert E. Harris; Paul-James Jones; Ji-Young Kim; Jon C. Lorenz; Keith B. Mckellop; Erin M. O'brien; Fenghe Qiu; Robert D. Simpson; Lana Smith; Regina C. So; Earl Spinelli; Jana Vitous; Chiara Zavattaro


Tetrahedron Letters | 2008

Preparation of 3-substituted-2-pyridin-2-ylindoles: regioselectivity of Larock’s indole annulation with 2-alkynylpyridines

Frank Roschangar; Jianxiu Liu; Emilie Estanove; Marine Dufour; Sonia Rodriguez; Vittorio Farina; Eugene R. Hickey; Azad Hossain; Paul-James Jones; Heewon Lee; Bruce Z. Lu; Richard J. Varsolona; Jürgen Schröder; Pierre L. Beaulieu; James Gillard; Chris H. Senanayake

Collaboration


Dive into the Paul-James Jones's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge